A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) ...
SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced the publication of the first human SPECT images ...
Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by motor and nonmotor symptoms. PD is often misdiagnosed; inappropriate treatment due to misdiagnosis has ...
U.S. Molecular Imaging Market Projected to Hit USD 5.06 Billion and Europe USD 4.11 Billion by 2035, Supported by Advanced Imaging Technologies, Research Funding, and Expanding PET AdoptionAustin, ...
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe ...
Does a patient have depression or a cognitive disorder (CD) such as Alzheimer's disease or both? Since both disorders have overlapping symptoms, how can a clinician tell them apart to make an ...
Patients who received cardiac PET imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe obstructive coronary artery ...
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe ...
SHINE acquires Billerica manufacturing facility and established SPECT product portfolio, expanding leadership in nuclear medicine JANESVILLE, Wis., Jan. 2, 2026 /PRNewswire/ -- SHINE announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results